PATENT CLAIM ANALYSIS

Application Number: 16073285
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "095000"]

Abstract:
It is intended to provide a novel bisphosphonic acid compound or a salt thereof which shows a remarkable inhibitory effect on ectopic calcification, and a pharmaceutical composition comprising the same. The present invention provides a bisphosphonic acid compound represented by the following formula (1) or a pharmaceutically acceptable salt thereof: wherein   represents a single bond or a double bond; A represents a saturated cyclic hydrocarbon or a saturated heterocyclic ring comprising a sulfur atom or an oxygen atom; and R 1  and R 2  each independently represent an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an aryloxy group, a haloalkoxy group, a haloalkyl group, a halogen atom or a hydrogen atom.

Claim (Index 12):
A method for producing a therapeutic drug for a disease associated with ectopic calcification, the method comprising:\n contacting the bisphosphonic acid compound according to  claim 1  with a pharmaceutical additive.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 95.0
- Lexical Diversity: 1.75676
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12811602', '15548303', '13120078', '12912514', '15328223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7291147385676711
- 35 USC 102 Novelty (BERT): 0.5176081183035921
- Combined Prediction Score: 0.7079640765412631
- Mean Citation Score: 245.031614
- Max Citation Score: 256.98575
- Similarity Product: 159.6696533202529

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test